DEEP DIVE

GHK-Cu

What is GHK-Cu?

GHK-Cu is a short peptide bound to copper. GHK stands for glycine, histidine and lysine, its three amino acids. Researchers study it in skin, wound and gene-activity models.

Last updated: 2026-10-08

At a Glance

Full Name: Glycyl-L-histidyl-L-lysine:copper(II) complex
Abbreviation: GHK-Cu
Class: Copper-binding tripeptide (naturally occurring)
Molecular Weight: 403.93 Da (GHK-Cu complex)
Discovery: 1973 — Loren Pickart, Biochemistry
Natural Source: Human plasma, saliva, and urine
Plasma Levels: ~200 ng/mL (age 20) → ~80 ng/mL (age 60)
Copper Binding: Kd = 10⁻¹⁶·⁴ M (extremely tight)
Genes Modulated: 4,000+ (Broad Institute Connectivity Map, 2010)
Clinical Stage: Widely used in cosmeceuticals; research-grade for investigational use

Why is GHK-Cu studied?

GHK was first studied in human plasma in 1973. Plasma is the liquid part of blood. GHK can bind copper, forming the complex called GHK-Cu.

The cited literature covers skin, wounds and tissue remodeling. Remodeling means the breakdown and rebuilding of tissue structure. Some studies examine cells, while others examine animals or specific skin formulations.

Gene-expression studies are another research area. Gene expression describes which genetic instructions a cell is using. A changed gene pattern is not proof of tissue repair or reversed aging.

How does GHK-Cu work in research models?

Research focuses on copper binding and changes in cell activity. Copper is involved in several enzymes. Binding copper to a peptide is different from exposing cells to free copper.

Fibroblasts are cells that help build connective tissue. Studies examine how these cells respond and how collagen production changes. Collagen is a structural protein found in skin and other tissues.

The extracellular matrix is the material around cells that supports tissue structure. Researchers measure both its production and breakdown. Gene-expression results offer clues but do not establish a universal repair mechanism.

GHK-Cu's Dual Mechanism

1

Copper Ion Delivery

GHK binds copper. Researchers study how that binding affects copper-related cell processes.

2

Collagen & ECM Stimulation

Collagen is a structural protein. Studies measure its production and the breakdown of surrounding tissue material.

3

Fibroblast & Stem Cell Activation

Fibroblasts help build connective tissue. Experiments examine their growth, movement and responses to GHK-Cu.

4

Anti-Inflammatory Gene Regulation

Gene-expression experiments measure changes in inflammatory signals. A changed gene pattern does not establish a clinical benefit.

5

Antioxidant Defense Enhancement

Antioxidant enzymes help manage reactive molecules in cells. Studies examine these systems and markers of oxidative stress.

6

Genome-Wide Reset

Gene-expression screens report many changes in cell activity. This is not proof of a genome reset or reversed aging.

What does the evidence show?

The findings below cover several kinds of evidence. Wound chambers, cell cultures and skin creams test different materials and outcomes. Results cannot be transferred freely between them.

Human skin findings apply to the formulation and conditions studied. They do not validate injectable use of a research vial. Some inherited references below lack full study details and should be checked in the original publication.

Wound Healing Acceleration

In controlled studies, GHK-Cu-containing wound chambers increased new tissue formation by up to 4x compared to controls. Wounds treated with GHK-Cu showed enhanced angiogenesis, collagen deposition, and epithelial closure rates.

Pickart L, J Biomater Sci, 2008

Skin Rejuvenation (Human Trials)

In 71 women, GHK-Cu cream significantly improved skin density (+25.4%), thickness (+28.9%), and reduced wrinkle depth compared to vehicle control and vitamin C after 12 weeks of application. Also improved skin clarity and reduced photodamage.

Leyden JJ, et al. (multiple controlled studies)

Hair Growth Stimulation

GHK-Cu increased hair follicle size, stimulated hair growth rate, and extended the anagen (growth) phase in both animal and human studies. 5-alpha reductase inhibition and increased blood flow to follicles contribute to the effect. Hair follicle density increased significantly vs. placebo.

Pickart L, Skin Biology, 2015

Lung Tissue Remodeling (COPD)

Connectivity Map analysis identified GHK-Cu as a potential COPD therapeutic. Gene expression profiling showed GHK-Cu reversed the COPD-associated gene signature toward a healthy pattern. This has led to exploratory inhaled GHK-Cu research.

Campbell JD, et al., PLoS One, 2012

Anti-Cancer Gene Modulation

GHK-Cu upregulated 47 genes associated with tumor suppression (including caspase genes and DNA damage response genes) while downregulating pro-metastatic genes. Gene modulation analysis suggests anti-cancer properties independent of cytotoxicity.

Pickart L, et al., Anti-Cancer Drugs, 2014

Bone Regeneration

In osteoblast cultures and animal fracture models, GHK-Cu stimulated osteoblast differentiation, increased bone mineral deposition, and enhanced fracture healing outcomes.

Pyo HK, et al.; Pickart L, Biomed Res Int, 2015

GHK-Cu vs. Other Regenerative Peptides

GHK-Cu, BPC-157, Matrixyl and EGF differ in structure and research purpose. EGF means epidermal growth factor. The comparison helps identify research questions rather than select a treatment.

A mechanism reported for one component does not establish a combined effect. Claims of synergy need direct combination evidence. Identity and formulation also matter when comparing studies.

PropertyGHK-CuBPC-157Matrixyl (Palmitoyl Pentapeptide)EGF (Epidermal Growth Factor)
OriginNaturally occurring (human plasma)Gastric juice fragmentSynthetic collagen fragmentNatural growth factor
Size3 amino acids + Cu²⁺ (403 Da)15 amino acids (1,419 Da)5 amino acids + palmitate53 amino acids (6,045 Da)
Genes Modulated4,000+ (6% of genome)Multiple pathways (not genome-mapped)Collagen-specific signalingEGF receptor cascade
Collagen EffectTypes I, III, V + elastin + GAGsIndirect (via healing)Types I and IIIIndirect (via proliferation)
Anti-InflammatoryStrong (NF-κB suppression)Moderate (NO system)MinimalMinimal
Copper DeliveryPrimary functionNoneNoneNone
Topical EfficacyWell-established (cosmeceutical)Limited evidenceWell-establishedModerate (stability issues)
Key AdvantageBroadest gene modulationBroadest tissue repairCosmeceutical gold standardStrongest proliferative signal

What are the limits of the safety evidence?

Topical studies do not establish safety for other forms of exposure. A naturally occurring peptide is not automatically safe in every formulation. Copper content and the tested material both matter.

Read the safety observations within their study limits. The absence of a reported adverse event does not exclude rare or long-term harm. This page gives no administration advice.

Topical Use: No significant adverse effects in multiple controlled human trials; no skin irritation or sensitization
Injectable (Preclinical): No reported toxicity at therapeutic doses in animal models
Copper Considerations: Study-specific safety observations do not establish a personal-use protocol. Read the original source and its limitations.
Drug Interactions: No known significant interactions; theoretical consideration with other copper-modulating compounds

What questions remain for future research?

Future research questions include tissue remodeling, gene activity and responses to aging. A gene signature is a pattern of gene activity. Reversing a signature in a model does not prove reversal of a disease.

The lung-related literature raises questions for further experiments. It does not establish a lung treatment. Human longevity claims also need direct human evidence.

Frequently Asked Questions

What is GHK-Cu?
GHK-Cu is a short peptide bound to copper. GHK stands for glycine, histidine and lysine, its three amino acids. Researchers study it in skin, wound and gene-activity models.
How does GHK-Cu affect the skin?
GHK-Cu stimulates collagen synthesis (types I, III, V), elastin production, and glycosaminoglycan formation while reducing collagen breakdown. In controlled human trials of topical use, skin density rose 25% and thickness 29%, and wrinkle depth fell. It outperformed vitamin C creams in head-to-head comparisons.
Does GHK-Cu promote hair growth?
Yes. GHK-Cu has been shown to increase hair follicle size, stimulate growth rate, and extend the anagen growth phase. It also inhibits 5-alpha reductase (the enzyme targeted by finasteride) and increases blood flow to hair follicles. Multiple studies have demonstrated increased hair density vs. placebo.
Why do GHK-Cu levels decline with age?
GHK-Cu plasma levels fall from ~200 ng/mL at age 20 to ~80 ng/mL by age 60, paralleling the decline in tissue repair capacity. The mechanism of this decline is not fully understood but may relate to reduced hepatic synthesis. Restoring GHK-Cu to youthful levels is a central hypothesis in anti-aging peptide research.
How does GHK-Cu compare to BPC-157?
GHK-Cu is studied in copper binding and tissue remodeling. BPC-157 research examines several injury-related signaling pathways. Different mechanisms do not establish synergy.
Is GHK-Cu safe?
Safety evidence depends on the preparation and exposure studied. Topical findings do not establish injectable safety. A natural origin does not rule out harm.

References

  1. [1] Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988.
  2. [2] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
  3. [3] Campbell JD, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67.
  4. [4] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
  5. [5] Leyden JJ, et al. Facial skin rejuvenation by copper peptide-containing cream (multiple controlled trials).
  6. [6] Lamb J, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929-1935.
Browse All Research Peptides →